The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria
Mortality and recurrence rates of hepatocellular carcinoma (HCC) are high. Recent studies show that for patients with HCC beyond up-to-seven criteria, treatment with molecular-targeted agents (MTAs) is recommended because the treatment efficiency of transcatheter arterial chemoembolization (TACE) is...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
MDPI AG
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/b7581f6e13ef4e4f80e61dab9184124c |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:b7581f6e13ef4e4f80e61dab9184124c |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:b7581f6e13ef4e4f80e61dab9184124c2021-11-11T17:30:27ZThe Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria10.3390/jcm102148382077-0383https://doaj.org/article/b7581f6e13ef4e4f80e61dab9184124c2021-10-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/21/4838https://doaj.org/toc/2077-0383Mortality and recurrence rates of hepatocellular carcinoma (HCC) are high. Recent studies show that for patients with HCC beyond up-to-seven criteria, treatment with molecular-targeted agents (MTAs) is recommended because the treatment efficiency of transcatheter arterial chemoembolization (TACE) is poor; further, TACE increases decline in liver function. However, the relationship between TACE and liver function decline in patients with HCC within up-to-seven criteria has not been clarified. Hence, we aimed to investigate this relationship. This retrospective observational study included 189 HCC tumors within up-to-seven criteria in 114 Child–Pugh class A patients. Twenty-four (12.7%) tumors were changed from Child–Pugh class A to B after TACE, and 116 (61.4%) tumors exhibited recurrence within 6 months after TACE. Prothrombin time (PT) and albumin–bilirubin (ALBI) score before TACE were significantly associated with liver dysfunction from Child–Pugh class A to B. The combination of PT and ALBI score before TACE had high predictive ability for liver dysfunction from Child–Pugh class A to B after TACE (specificity = 100%, sensitivity = 91.7%). The combined use of pre-TACE PT and ALBI score has a high predictive ability for liver dysfunction after TACE for Child–Pugh class A patients with HCC within up-to-seven criteria.Hiroaki TakayaTadashi NamisakiSoichi TakedaKosuke KajiHiroyuki OgawaKoji IshidaYuki TsujiHirotetsu TakagiTakahiro OzutsumiYukihisa FujinagaMasanori FurukawaKoh KitagawaNorihisa NishimuraYasuhiko SawadaNaotaka ShimozatoHideto KawarataniKei MoriyaTakemi AkahaneAkira MitoroHitoshi YoshijiMDPI AGarticlealbuminbilirubintherapeutic chemoembolizationhepatocellular carcinomaliver dysfunctionMedicineRENJournal of Clinical Medicine, Vol 10, Iss 4838, p 4838 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
albumin bilirubin therapeutic chemoembolization hepatocellular carcinoma liver dysfunction Medicine R |
| spellingShingle |
albumin bilirubin therapeutic chemoembolization hepatocellular carcinoma liver dysfunction Medicine R Hiroaki Takaya Tadashi Namisaki Soichi Takeda Kosuke Kaji Hiroyuki Ogawa Koji Ishida Yuki Tsuji Hirotetsu Takagi Takahiro Ozutsumi Yukihisa Fujinaga Masanori Furukawa Koh Kitagawa Norihisa Nishimura Yasuhiko Sawada Naotaka Shimozato Hideto Kawaratani Kei Moriya Takemi Akahane Akira Mitoro Hitoshi Yoshiji The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria |
| description |
Mortality and recurrence rates of hepatocellular carcinoma (HCC) are high. Recent studies show that for patients with HCC beyond up-to-seven criteria, treatment with molecular-targeted agents (MTAs) is recommended because the treatment efficiency of transcatheter arterial chemoembolization (TACE) is poor; further, TACE increases decline in liver function. However, the relationship between TACE and liver function decline in patients with HCC within up-to-seven criteria has not been clarified. Hence, we aimed to investigate this relationship. This retrospective observational study included 189 HCC tumors within up-to-seven criteria in 114 Child–Pugh class A patients. Twenty-four (12.7%) tumors were changed from Child–Pugh class A to B after TACE, and 116 (61.4%) tumors exhibited recurrence within 6 months after TACE. Prothrombin time (PT) and albumin–bilirubin (ALBI) score before TACE were significantly associated with liver dysfunction from Child–Pugh class A to B. The combination of PT and ALBI score before TACE had high predictive ability for liver dysfunction from Child–Pugh class A to B after TACE (specificity = 100%, sensitivity = 91.7%). The combined use of pre-TACE PT and ALBI score has a high predictive ability for liver dysfunction after TACE for Child–Pugh class A patients with HCC within up-to-seven criteria. |
| format |
article |
| author |
Hiroaki Takaya Tadashi Namisaki Soichi Takeda Kosuke Kaji Hiroyuki Ogawa Koji Ishida Yuki Tsuji Hirotetsu Takagi Takahiro Ozutsumi Yukihisa Fujinaga Masanori Furukawa Koh Kitagawa Norihisa Nishimura Yasuhiko Sawada Naotaka Shimozato Hideto Kawaratani Kei Moriya Takemi Akahane Akira Mitoro Hitoshi Yoshiji |
| author_facet |
Hiroaki Takaya Tadashi Namisaki Soichi Takeda Kosuke Kaji Hiroyuki Ogawa Koji Ishida Yuki Tsuji Hirotetsu Takagi Takahiro Ozutsumi Yukihisa Fujinaga Masanori Furukawa Koh Kitagawa Norihisa Nishimura Yasuhiko Sawada Naotaka Shimozato Hideto Kawaratani Kei Moriya Takemi Akahane Akira Mitoro Hitoshi Yoshiji |
| author_sort |
Hiroaki Takaya |
| title |
The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria |
| title_short |
The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria |
| title_full |
The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria |
| title_fullStr |
The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria |
| title_full_unstemmed |
The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria |
| title_sort |
combination of albumin–bilirubin score and prothrombin time is a useful tool for predicting liver dysfunction after transcatheter arterial chemoembolization in child–pugh class a patients with hepatocellular carcinoma within up-to-seven criteria |
| publisher |
MDPI AG |
| publishDate |
2021 |
| url |
https://doaj.org/article/b7581f6e13ef4e4f80e61dab9184124c |
| work_keys_str_mv |
AT hiroakitakaya thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT tadashinamisaki thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT soichitakeda thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT kosukekaji thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT hiroyukiogawa thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT kojiishida thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT yukitsuji thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT hirotetsutakagi thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT takahiroozutsumi thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT yukihisafujinaga thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT masanorifurukawa thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT kohkitagawa thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT norihisanishimura thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT yasuhikosawada thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT naotakashimozato thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT hidetokawaratani thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT keimoriya thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT takemiakahane thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT akiramitoro thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT hitoshiyoshiji thecombinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT hiroakitakaya combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT tadashinamisaki combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT soichitakeda combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT kosukekaji combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT hiroyukiogawa combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT kojiishida combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT yukitsuji combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT hirotetsutakagi combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT takahiroozutsumi combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT yukihisafujinaga combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT masanorifurukawa combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT kohkitagawa combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT norihisanishimura combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT yasuhikosawada combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT naotakashimozato combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT hidetokawaratani combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT keimoriya combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT takemiakahane combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT akiramitoro combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria AT hitoshiyoshiji combinationofalbuminbilirubinscoreandprothrombintimeisausefultoolforpredictingliverdysfunctionaftertranscatheterarterialchemoembolizationinchildpughclassapatientswithhepatocellularcarcinomawithinuptosevencriteria |
| _version_ |
1718432085385936896 |